Faculty

Institution

Unit

Venue

Ben George

Oncologist

Medical College of Wisconsin

Affiliations

Pancreatic Cancer Program

Ben George is currently serving as a Pancreatic Cancer Program Oncologist at Medical College of Wisconsin.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Ben George

Medical College of Wisconsin

Oncologist

You can click a keyword to filter the displayed items

oncology cancer research pancreatic cancer cancer treatment pharmacology surgical oncology cancer care medicine cancer genomics molecular cancer cancer genetics surgery urology cancer discovery cancer management tumor biology genomics cancer cells genome biology oncogenes molecular diagnostics cancer biology gastrointestinal oncology bladder cancer cellular therapy pancreatic ductal adenocarcinoma gastroenterology hepatology thoracic oncology genitourinary cancers colorectal cancer esophageal cancer anti-cancer agents neoadjuvant therapy human genetics biomedical informatics biliary cancer genomic medicine medical genetics liver cancer immune checkpoint inhibitors localized pancreatic cancer digestive diseases cell transplantation surgical education clinical transplantation genetic programming malignant disease clinical surgery colorectal surgery clinical implementation covid-19 pandemic urological research perineural invasion tumor suppressors continuous delivery regional relevance gene expression profiling prognostic biomarkers computed tomography oncologic imaging molecular pathology mutagenesis comprehensive analysis human cancer multiple basket study phase 2a genome profile analysis prb expression neoadjuvant folfirinox genomic predictors resectable pancreatic cancer arterial resection colorectal liver metastases systematic review extra hepatic disease radiation oncology precision medicine cancer letter

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract A008: Intracranial Metastases in Patients With Claudin 18.2 Positive Metastatic Gastroesophageal Cancers. Cancer Research (2025)

Kavanya FeustelLisa ReinAlexandria PhanMandana KamgarRazelle KurzrockAniko SzaboBen George

metastasisesophageal cancerintracranial metastasescancer research

Abstract Ct079: Pharmacodynamic (Pd) and Exploratory Biomarker (Bm) Analysis of the Prmt5 Inhibitor Bms-986504 in Patients (Pts) With Advanced Solid Tumors With Homozygous Mtap Deletion ( Mtap -Del). Cancer Research (2025)

anti-cancer agentsoncologyradiation oncologymolecular cancerhomozygous mtap deletiononcogenespharmacologycancer treatmenttherapeutic targetsprmt5 inhibitor bms-986504cancer discoveryadvanced solid tumors

AI-Derived Electronic Tumor Marker (E19-9) Can Measure Treatment Response and Outcomes in Ca19-9 Non-Producers With Pancreatic Ductal Adenocarcinoma. Research Square (2025)

Anai KothariSam ThaljiMohammed AldakkakGopika SenthilKumarMouloud BelbahriTahseen ShaikTaylor JaraczewskiJennifer MerrillAdhitya RamamurthiAnjishnu BanerjeeBradley TaylorMandana KamgarBen GeorgeBeth EricksonWilliam HallNikki LytleYongwoo SeoKathleen ChristiansCallisia ClarkeDouglas EvansSusan Tsai

pancreatic ductal adenocarcinomacancer researchtreatment responsebiostatisticstumor targetingbiomarkers

Bms-986504 in Patients (Pts) With Advanced Solid Tumors With Homozygous Mtap Deletion ( Mtap -Del): Clinical Update and First Report of Pharmacokinetics (Pk) and Pharmacodynamic (Pd) Analyses From Ca240-0007.. Journal of Clinical Oncology (2025)

anti-cancer agentssarcomaoncologyradiation oncologycancer researchclinical updatepharmacologycancer treatmenttherapeutic targetsjama oncologycancer discoverypharmacotherapyadvanced solid tumorsfirst report

Effect of Enrollment in a Clinical Trial on Treatment Outcomes of Patients With Pancreas Cancer.. Journal of Clinical Oncology (2025)

pancreas cancersurgical oncologymedicineoncologyradiation oncologycancer researchgastrointestinal oncologypancreatic cancerhealth policycancer managementcancer caretreatment outcomesclinical trials

Mek Inhibitor-Based Therapy in Metastatic Pancreatic Adenocarcinoma With Kras G12R Alteration.. Journal of Clinical Oncology (2025)

Elizabeth AuckleyGrace YingStephanie YohayMohammed AldakkakSamih Z ThaljiParnian VakiliJustin GrahlBradley MayerFaisal ShahjehanSoon Khai LowDouglas B. EvansKathleen K. ChristiansYongwoo David SeoBeth EricksonWilliam Adrian HallThomas McFallRazelle KurzrockBen GeorgeMandana Kamgar

metastatic pancreatic adenocarcinomamek inhibitor-based therapypharmacologytherapeutic targetsmetastasistumor biologycellular therapycancer researchoncologysystems biologycancer treatmentcancer discoverynovel therapiespancreatic cancerimmunologytumor targetingmedicinal researchcancer cellsoncogenestreatment development

Abstract Ct080: A Phase I Study of Cpi-613 (Devimistat) in Combination With Chemoradiation in Patients With Pancreatic Ductal Adenocarcinoma. Cancer Research (2024)

Mandana KamgarHusain Yar KhanAmro AboukameelSahar F. BannouraBrian Y. ChungAniko SzaboYiwei LiMohammed Najeeb Al HallakPhilip A. PhilipBen GeorgeKathleen K. ChristiansDouglas B. EvansSusan TsaiBeth EricksonJohn M. GoldbergAsfar S. AzmiWilliam A. Hall

tumor biologypancreatic ductal adenocarcinomacancer imagingcancer researchradiation oncologyoncologycancer biologyoncologic imagingmedical imagingcancer treatmentradiologyclinical researchhealth sciencescomputed tomography

An Analytical Approach That Combines Knowledge From Germline and Somatic Mutations Enhances Tumor Genomic Reanalyses in Precision Oncology. Journal of Computational Biology (2024)

Elias DeVoeHoney V. ReddiBradley W. TaylorSamantha StachowiakJennifer L. GeurtsBen GeorgeReza ShakerRaul UrrutiaMichael T. Zimmermann

cancer genomicssystems biologycomputational biologygenomic reanalysesprecision oncology

Successful Targeting of Somatic Vhl Alterations With Belzutifan in Two Cases. Journal of Immunotherapy and Precision Oncology (2024)

Bicky ThapaAditya ShreenivasKathryn BylowHui-Zi ChenBen GeorgeRazelle Kurzrock

cancer immunotherapyoncologyimmunotherapyimmunologytumor targeting

Aso Visual Abstract: Ca19-9 Response to First-Line Neoadjuvant Folfirinox and Second-Line Gemcitabine/ Nab-Paclitaxel for Patients With Operable Pancreatic Cancer. Annals of Surgical Oncology (2023)

Sam Z. ThaljiMandana KamgarBen GeorgeMohammed AldakkakKathleen K. ChristiansCallisia N. ClarkeBeth A. EricksonWilliam A. HallParag P. TolatZachary L. SmithDouglas B. EvansSusan Tsai

hepatologysurgical oncologytherapeutic efficacymedicineanti-cancer agentsfirst-line neoadjuvant folfirinoxoncologyradiation oncologycancer researchpancreatic cancercancer managementmedical mycologycancer carethoracic oncologypharmacologycancer treatmentcervical canceroperable pancreatic cancer

1
2
3
4
5
10 / page

Ben George

Oncologist

Medical College of Wisconsin

Affiliations

Pancreatic Cancer Program

Ben George is currently serving as a Pancreatic Cancer Program Oncologist at Medical College of Wisconsin.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Ben George

Medical College of Wisconsin

Oncologist

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abstract A008: Intracranial Metastases in Patients With Claudin 18.2 Positive Metastatic Gastroesophageal Cancers. Cancer Research (2025)

Kavanya FeustelLisa ReinAlexandria PhanMandana KamgarRazelle KurzrockAniko SzaboBen George

metastasisesophageal cancerintracranial metastasescancer research

AI-Derived Electronic Tumor Marker (E19-9) Can Measure Treatment Response and Outcomes in Ca19-9 Non-Producers With Pancreatic Ductal Adenocarcinoma. Research Square (2025)

pancreatic ductal adenocarcinomacancer researchtreatment responsebiostatisticstumor targetingbiomarkers

Effect of Enrollment in a Clinical Trial on Treatment Outcomes of Patients With Pancreas Cancer.. Journal of Clinical Oncology (2025)

pancreas cancersurgical oncologymedicineoncologyradiation oncologycancer researchgastrointestinal oncologypancreatic cancerhealth policycancer managementcancer caretreatment outcomesclinical trials

Mek Inhibitor-Based Therapy in Metastatic Pancreatic Adenocarcinoma With Kras G12R Alteration.. Journal of Clinical Oncology (2025)

Abstract Ct080: A Phase I Study of Cpi-613 (Devimistat) in Combination With Chemoradiation in Patients With Pancreatic Ductal Adenocarcinoma. Cancer Research (2024)

An Analytical Approach That Combines Knowledge From Germline and Somatic Mutations Enhances Tumor Genomic Reanalyses in Precision Oncology. Journal of Computational Biology (2024)

Elias DeVoeHoney V. ReddiBradley W. TaylorSamantha StachowiakJennifer L. GeurtsBen GeorgeReza ShakerRaul UrrutiaMichael T. Zimmermann

cancer genomicssystems biologycomputational biologygenomic reanalysesprecision oncology

Successful Targeting of Somatic Vhl Alterations With Belzutifan in Two Cases. Journal of Immunotherapy and Precision Oncology (2024)

Bicky ThapaAditya ShreenivasKathryn BylowHui-Zi ChenBen GeorgeRazelle Kurzrock

cancer immunotherapyoncologyimmunotherapyimmunologytumor targeting

Sam Z. ThaljiMandana KamgarBen GeorgeMohammed AldakkakKathleen K. ChristiansCallisia N. ClarkeBeth A. EricksonWilliam A. HallParag P. TolatZachary L. SmithDouglas B. EvansSusan Tsai

1
2
3
4
5
10 / page

Similar Faculty Members

Davendra Sohal, MD

Institution

University of Cincinnati

radiation oncology

colorectal cancer

William A. Hall, MD

Institution

Medical College of Wisconsin

radiation oncology

cancer research

William Hawkins, M.D

Institution

Medical University of South Carolina

cancer research

oncology

Ignacio Garrido-Laguna

Institution

University of Utah

pathology

pancreatic ductal adenocarcinoma

Aatur Singhi

Institution

University of Pittsburgh

gastroenterology

molecular pathology

James Ford

Institution

Stanford University

personalized medicine

radiation oncology

Manish Kohli

Institution

University of Utah

urology

advanced prostate cancer

Jill Kolesar

Institution

University of Kentucky

oncology

pharmacology

Cora Sternberg

Institution

Weill Cornell Medicine

oncology

urology

Jen Yeh

Institution

University of North Carolina at Chapel Hill

pathology

molecular cancer

Similar Faculty Members

Davendra Sohal, MD

Institution

University of Cincinnati

radiation oncology

colorectal cancer

William A. Hall, MD

Institution

Medical College of Wisconsin

radiation oncology

cancer research

William Hawkins, M.D

Institution

Medical University of South Carolina

cancer research

oncology

Ignacio Garrido-Laguna

Institution

University of Utah

pathology

pancreatic ductal adenocarcinoma

Aatur Singhi

Institution

University of Pittsburgh

gastroenterology

molecular pathology

James Ford

Institution

Stanford University

personalized medicine

radiation oncology

Manish Kohli

Institution

University of Utah

urology

advanced prostate cancer

Jill Kolesar

Institution

University of Kentucky

oncology

pharmacology

Cora Sternberg

Institution

Weill Cornell Medicine

oncology

urology

Jen Yeh

Institution

University of North Carolina at Chapel Hill

pathology

molecular cancer